These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 35102279)
21. Predicting tumour content of liquid biopsies from cell-free DNA. Cardner M; Marass F; Gedvilaite E; Yang JL; Tsui DWY; Beerenwinkel N BMC Bioinformatics; 2023 Sep; 24(1):368. PubMed ID: 37777714 [TBL] [Abstract][Full Text] [Related]
22. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer. Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773 [TBL] [Abstract][Full Text] [Related]
23. Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling. Liu X; Yang M; Hu D; An Y; Wang W; Lin H; Pan Y; Ju J; Sun K Cell Rep Methods; 2024 Jun; 4(6):100793. PubMed ID: 38866008 [TBL] [Abstract][Full Text] [Related]
24. Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care. Sorbini M; Carradori T; Togliatto GM; Vaisitti T; Deaglio S Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672514 [TBL] [Abstract][Full Text] [Related]
25. NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay. Olbryt M; Rajczykowski M; Bal W; Fiszer-Kierzkowska A; Cortez AJ; Mazur M; Suwiński R; Widłak W Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356096 [TBL] [Abstract][Full Text] [Related]
26. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals. Xia L; Li Z; Zhou B; Tian G; Zeng L; Dai H; Li X; Liu C; Lu S; Xu F; Tu X; Deng F; Xie Y; Huang W; He J Sci Rep; 2017 Aug; 7(1):7526. PubMed ID: 28790338 [TBL] [Abstract][Full Text] [Related]
28. 'Longing' for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing. Yu SCY; Choy LYL; Lo YMD Mol Diagn Ther; 2023 Sep; 27(5):563-571. PubMed ID: 37474843 [TBL] [Abstract][Full Text] [Related]
29. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms. Grabuschnig S; Bronkhorst AJ; Holdenrieder S; Rosales Rodriguez I; Schliep KP; Schwendenwein D; Ungerer V; Sensen CW Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137955 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis and monitoring of virus-associated cancer using cell-free DNA. Scholte LL; Bethony JM; Xian RR Curr Opin Virol; 2023 Jun; 60():101331. PubMed ID: 37187125 [TBL] [Abstract][Full Text] [Related]
31. Circulating cell-free DNA for non-invasive cancer management. Stewart CM; Tsui DWY Cancer Genet; 2018 Dec; 228-229():169-179. PubMed ID: 29625863 [TBL] [Abstract][Full Text] [Related]
32. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814 [TBL] [Abstract][Full Text] [Related]
33. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
35. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA. Janku F; Huang HJ; Pereira DY; Kobayashi M; Chiu CH; Call SG; Woodbury KT; Chao F; Marshak DR; Chiu RYT Sci Rep; 2021 Oct; 11(1):19653. PubMed ID: 34608196 [TBL] [Abstract][Full Text] [Related]
36. Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control. Wu TM; Liu JB; Liu Y; Shi Y; Li W; Wang GR; Ma YS; Fu D Cancer Control; 2020; 27(3):1073274820934805. PubMed ID: 32806937 [TBL] [Abstract][Full Text] [Related]
37. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer. Balla A; Bhak J; Biró O Mol Cell Probes; 2022 Dec; 66():101871. PubMed ID: 36283501 [TBL] [Abstract][Full Text] [Related]
38. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
39. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future. Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578 [TBL] [Abstract][Full Text] [Related]
40. Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis. Palande V; Siegal T; Detroja R; Gorohovski A; Glass R; Flueh C; Kanner AA; Laviv Y; Har-Nof S; Levy-Barda A; Viviana Karpuj M; Kurtz M; Perez S; Raviv Shay D; Frenkel-Morgenstern M Mol Oncol; 2022 May; 16(10):2098-2114. PubMed ID: 34875133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]